tradingkey.logo
tradingkey.logo
Search

Metsera soars after FT reports Pfizer nearing $7.3 bln takeover

ReutersSep 22, 2025 8:41 AM
facebooktwitterlinkedin

Shares of obesity drug developer Metsera MTSR.O jump 50% to $50.24 premarket

The Financial Times reported on Sunday that Pfizer PFE.N is closing in on potential $7.3 bln takeover of MTSR, citing unidentified sources

PFE will acquire MTSR for $47.50 per share in cash, with an additional $22.50 per share contingent on the achievement of certain performance milestones

The $47.5 per share deal represents a 42.5% premium over MTSR's Friday closing price of $33.32; MTSR's market cap is $3.5 bln - according to data compiled by LSEG

Reuters could not immediately confirm the report

PFE shares up 1.6% premarket

Up to last close, MTSR stock up ~85% vs January IPO price of $18

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI